Wed, Mar 3rd, 2021
Subscribe
Log In
Lists
Book of Lists
The Money Issue
LA500
Wealthiest Angelenos
Health Care
Real Estate
Finance
Manufacturing
Tech
Infrastructure
Travel/Leisure
Media
Professional Services
Events
2021 Events
2020 Events
2019 Events
Custom Features
Custom Content
Trusted Advisors
People on the Move
Companies on the Move
Videos
×
Los Angeles Business Journal
Orange County Business Journal
San Diego Business Journal
San Fernando Valley Business Journal
Subscribe
Follow
Follow our NEWS
Facebook
Twitter
Instagram
LinkedIn
Follow our EVENTS
Facebook
Twitter
Instagram
Email Alerts
Log In
Search
×
Wednesday, March 03, 2021
Wed, Mar 3rd, 2021
Subscribe
Log In
Lists
Book of Lists
The Money Issue
LA500
Wealthiest Angelenos
Health Care
Real Estate
Finance
Manufacturing
Tech
Infrastructure
Travel/Leisure
Media
Professional Services
Events
2021 Events
2020 Events
2019 Events
Custom Features
Custom Content
Trusted Advisors
People on the Move
Companies on the Move
Videos
Home
Bradway, Robert — Amgen Inc
Chief Executive and Chairman
Amgen Inc.
THE LATEST: In January, Amgen strengthened its presence in China — the world's second-largest pharmaceutical market — by establishing a strategic partnership with Beijing-based biotechnology company BeiGene, focused on development of cancer therapies. Bradway has said he expects 25% of the company&s growth to come from Asian markets during the next decade. In October, Bradway told securities analysts Amgen will focus on developing drugs to treat cancer, cardiovascular disease and inflammatory disease. The company plans to phase out development of drugs to treat neurological diseases and conditions.
BACKGROUND: Bradway joined Amgen in 2006, becoming chief executive in 2012 and board chairman a year later. Prior to Amgen, he worked as managing director at Morgan Stanley in London. He is a member of USC's board of trustees and the advisory board of the Leonard D. Schaeffer Center for Health Policy and Economics at USC. He's on the board at the Pharmaceutical Research and Manufacturers of America and chairman of the CEO Roundtable on Cancer, a nonprofit devoted to cancer treatment and prevention.
YEARS ON THE LA500: 5
Return to the 2020 edition of the LA500.